XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY (UNAUDITED) - USD ($)
Total
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balance, shares at Dec. 31, 2023   927,904 107,647,317    
Balance, amount at Dec. 31, 2023 $ 25,520,968 $ 9,279 $ 1,076,472 $ 63,853,836 $ (39,418,619)
Net loss (322,768) 0 0 0 (322,768)
Share-based compensation 205,925 0 $ 0 205,925 0
Distribution of restricted stock units, shares     791,667    
Distribution of restricted stock units, amount 0 $ 0 $ 7,917 (7,917) 0
Balance, shares at Mar. 31, 2024   927,904 108,438,984    
Balance, amount at Mar. 31, 2024 25,404,125 $ 9,279 $ 1,084,389 64,051,844 (39,741,387)
Balance, shares at Dec. 31, 2023   927,904 107,647,317    
Balance, amount at Dec. 31, 2023 25,520,968 $ 9,279 $ 1,076,472 63,853,836 (39,418,619)
Net loss (119,976)        
Balance, shares at Jun. 30, 2024   927,904 108,438,984    
Balance, amount at Jun. 30, 2024 25,701,839 $ 9,279 $ 1,084,389 64,146,766 (39,538,595)
Balance, shares at Mar. 31, 2024   927,904 108,438,984    
Balance, amount at Mar. 31, 2024 25,404,125 $ 9,279 $ 1,084,389 64,051,844 (39,741,387)
Net loss 202,792 0 0 0 202,792
Share-based compensation 94,922 $ 0 $ 0 94,922 0
Balance, shares at Jun. 30, 2024   927,904 108,438,984    
Balance, amount at Jun. 30, 2024 25,701,839 $ 9,279 $ 1,084,389 64,146,766 (39,538,595)
Balance, shares at Dec. 31, 2024   927,904 112,951,317    
Balance, amount at Dec. 31, 2024 28,600,673 $ 9,279 $ 1,129,512 68,610,905 (41,149,023)
Net loss 546,524 0 0 0 546,524
Share-based compensation 245,384 0 $ 0 245,384 0
Exercise of stock options and distribution of restricted stock units, shares     1,101,231    
Exercise of stock options and distribution of restricted stock units, amount 0 0 $ 11,013 (11,013) 0
Issuance of common stock for cash, net of issuance costs, shares     1,107,923    
Issuance of common stock for cash, net of issuance costs, amount 2,392,317 0 $ 11,079 2,381,238 0
Issuance of common stock upon exercise of warrants, shares     948,750    
Issuance of common stock upon exercise of warrants, amount 806,438 $ 0 $ 9,488 796,950 0
Balance, shares at Mar. 31, 2025   927,904 116,109,221    
Balance, amount at Mar. 31, 2025 32,591,336 $ 9,279 $ 1,161,092 72,023,464 (40,602,499)
Balance, shares at Dec. 31, 2024   927,904 112,951,317    
Balance, amount at Dec. 31, 2024 28,600,673 $ 9,279 $ 1,129,512 68,610,905 (41,149,023)
Net loss $ 728,079        
Balance, shares at Jun. 30, 2025 2,919,643 927,904 119,200,980    
Balance, amount at Jun. 30, 2025 $ 37,505,943 $ 9,279 $ 1,192,010 76,725,598 (40,420,944)
Balance, shares at Mar. 31, 2025   927,904 116,109,221    
Balance, amount at Mar. 31, 2025 32,591,336 $ 9,279 $ 1,161,092 72,023,464 (40,602,499)
Net loss 181,555 0 0 0 181,555
Share-based compensation 586,913 0 $ 0 586,913 0
Exercise of stock options and distribution of restricted stock units, shares     370,866    
Exercise of stock options and distribution of restricted stock units, amount 55,000 0 $ 3,709 51,291 0
Issuance of common stock for cash, net of issuance costs, shares     750,000    
Issuance of common stock for cash, net of issuance costs, amount 2,672,166 0 $ 7,500 2,664,666 0
Issuance of common stock upon exercise of warrants, shares     1,970,893    
Issuance of common stock upon exercise of warrants, amount $ 1,418,973 $ 0 $ 19,709 1,399,264 0
Balance, shares at Jun. 30, 2025 2,919,643 927,904 119,200,980    
Balance, amount at Jun. 30, 2025 $ 37,505,943 $ 9,279 $ 1,192,010 $ 76,725,598 $ (40,420,944)